共 38 条
[1]
Survival following dementia onset: Alzheimer’s disease and vascular dementia. Fitzpatrick,AL,Kuller,LH,Lopez,OL,Kawas,CH,Jagust,W. Journal of the Neurological Sciences . 2005
[2]
Escitalopram and en-hancement of cognitive recovery following stroke. Jorge RE,Acion L,Moser D,et al. Archives of General Psychiatry . 2010
[3]
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Forette F, Seux ML, Staessen JA, et al. The Lancet . 1998
[4]
Antihypertensive drugs and incidence of dementia: the Rotterdam Study[J] . B.A in’t Veld,A Ruitenberg,A Hofman,B.H.Ch Stricker,M.M.B Breteler.  Neurobiology of Aging . 2001 (3)
[6]
Donepezil in vascular dementia: A randomized, placebo-controlled study[J] . D. Wilkinson,R. Doody,R. Helme,K. Taubman,J. Mintzer,A. Kertesz,R.D. Pratt.  Neurology . 2003 (4)
[7]
Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins[J] . Ivan Casserly,Eric J Topol.  The Lancet . 2004 (9415)
[8]
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards[J] . Vladimir Hachinski,Costantino Iadecola,Ron C. Petersen,Monique M. Breteler,David L. Nyenhuis,Sandra E. Black,William J. Powers,Charles DeCarli,Jose G. Merino,Raj N. Kalaria,Harry V. Vinters,David M. Holtzman,Gary A. Rosenberg,Anders Wallin,Martin Dichgans,John R. Marler,Gabrielle G. Leblanc.  Stroke . 2006 (9)
[9]
Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL[J] . Martin Dichgans,Hugh S Markus,Stephen Salloway,Auli Verkkoniemi,Margaret Moline,Qin Wang,Holly Posner,Hugues S Chabriat.  Lancet Neurology . 2008 (4)
[10]
Threats to the Mind: Aging, Amyloid, and Hypertension[J] . Costantino Iadecola,Laibaik Park,Carmen Capone.  Stroke . 2009 (3 Su)